{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T16:24:26Z","timestamp":1783441466147,"version":"3.54.6"},"reference-count":27,"publisher":"Walter de Gruyter GmbH","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Grant Agency of the Ministry of Education of the Slovak Republic and the Slovak Academy of Sciences","award":["2\/0030\/23"],"award-info":[{"award-number":["2\/0030\/23"]}]},{"name":"Grant Agency of the Ministry of Education of the Slovak Republic and the Slovak Academy of Sciences","award":["VEGA2\/0046\/24"],"award-info":[{"award-number":["VEGA2\/0046\/24"]}]},{"name":"Slovak Agency for Research and Development","award":["APVV-24-0167"],"award-info":[{"award-number":["APVV-24-0167"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,1,23]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Acute myeloid leukemia is a severe hematologic malignancy that predominantly affects older adults and is characterized by high biological variability. One of the main challenges in its treatment is the development of multidrug resistance, often mediated by the overexpression of P-glycoprotein (ABCB1). This transport protein actively expels cytotoxic drugs from cells, reducing the effectiveness of chemotherapy and worsening patient prognosis. Although several generations of P-glycoprotein inhibitors have been developed, their clinical use is significantly limited due to their negative side effects. In recent years, attention has shifted toward natural substances and well-known drugs with broad applications. A promising candidate is amantadine, a lipophilic compound with a stable structure, originally used to treat influenza and Parkinson\u2019s disease. This study focuses on investigating the potential of its derivatives in combating multidrug resistance in acute myeloid leukemia. The results demonstrate that the newly synthesized adamantane derivatives, particularly E-A2, exhibit significant cytotoxic activity in acute myeloid leukemia cell lines, including P-glycoprotein-expressing resistant variants. Importantly, E-A2 was able to induce both apoptotic and necrotic cell death and maintained its activity in multidrug resistant models.<\/jats:p>","DOI":"10.1515\/biol-2025-1340","type":"journal-article","created":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T11:57:17Z","timestamp":1782388637000},"source":"Crossref","is-referenced-by-count":0,"title":["Cellular effects of adamantane derivatives in P-glycoprotein leukemia cells"],"prefix":"10.1515","volume":"21","author":[{"given":"Natalia","family":"Dostalkova","sequence":"first","affiliation":[{"name":"Department of Biochemistry and Microbiology, Faculty of Chemical and Food Technology , Slovak University of Technology in Bratislava , Radlinskeho 9, SK-81237 , Bratislava , Slovak Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8567-3794","authenticated-orcid":false,"given":"Lucia","family":"Sofrankova","sequence":"additional","affiliation":[{"name":"Department of Biochemistry and Microbiology, Faculty of Chemical and Food Technology , Slovak University of Technology in Bratislava , Radlinskeho 9, SK-81237 , Bratislava , Slovak Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-1474-7113","authenticated-orcid":false,"given":"Jana","family":"Spaldova","sequence":"additional","affiliation":[{"name":"Department of Biochemistry and Microbiology, Faculty of Chemical and Food Technology , Slovak University of Technology in Bratislava , Radlinskeho 9, SK-81237 , Bratislava , Slovak Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1096-9830","authenticated-orcid":false,"given":"Branislav","family":"Pavilek","sequence":"additional","affiliation":[{"name":"Department of Organic Chemistry, Faculty of Chemical and Food Technology , Slovak University of Technology in Bratislava , Radlinskeho 9, SK-81237 , Bratislava , Slovak Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ester","family":"Pisarova","sequence":"additional","affiliation":[{"name":"Department of Organic Chemistry, Faculty of Chemical and Food Technology , Slovak University of Technology in Bratislava , Radlinskeho 9, SK-81237 , Bratislava , Slovak Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0107-9999","authenticated-orcid":false,"given":"Lakatos","family":"Boris","sequence":"additional","affiliation":[{"name":"Department of Biochemistry and Microbiology, Faculty of Chemical and Food Technology , Slovak University of Technology in Bratislava , Radlinskeho 9, SK-81237 , Bratislava , Slovak Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"374","published-online":{"date-parts":[[2026,6,26]]},"reference":[{"key":"2026070716010034873_j_biol-2025-1340_ref_001","doi-asserted-by":"crossref","unstructured":"Wachter, F, Pikman, Y. Pathophysiology of acute myeloid leukemia. Acta Haematol 2024;147:232\u201349. https:\/\/doi.org\/10.1159\/000536152.","DOI":"10.1159\/000536152"},{"key":"2026070716010034873_j_biol-2025-1340_ref_002","doi-asserted-by":"crossref","unstructured":"Zhou, M, Li, L, Li, L, Lin, X, Wang, F, Li, Q, et al.. Overcoming chemotherapy resistance via simultaneous drug-efflux circumvention and mitochondrial targeting. Acta Pharm Sin B 2018;9:615\u201325. https:\/\/doi.org\/10.1016\/j.apsb.2018.11.005.","DOI":"10.1016\/j.apsb.2018.11.005"},{"key":"2026070716010034873_j_biol-2025-1340_ref_003","unstructured":"Wuchter, C, Leonid, K, Ruppert, V, Schrappe, M, B\u00fcchner, T, Schoch, C, et al.. Clinical significance of P-glycoprotein expression and function for response to induction chemotherapy, relapse rate and overall survival in acute leukemia. Haematologica 2000;85:711\u201321."},{"key":"2026070716010034873_j_biol-2025-1340_ref_004","doi-asserted-by":"crossref","unstructured":"Raghava, KM, Lakshmi, PK. Overview of P-glycoprotein inhibitors: a rational outlook. Braz J Pharm Sci 2012;48:353\u201367.","DOI":"10.1590\/S1984-82502012000300002"},{"key":"2026070716010034873_j_biol-2025-1340_ref_005","doi-asserted-by":"crossref","unstructured":"Cui, J, Liu, X, Chow, LMC. Flavonoids as P-gp inhibitors: a systematic review of SARs. Curr Med Chem 2019;26:4799\u2013831. https:\/\/doi.org\/10.2174\/0929867325666181001115225.","DOI":"10.2174\/0929867325666181001115225"},{"key":"2026070716010034873_j_biol-2025-1340_ref_006","doi-asserted-by":"crossref","unstructured":"Umsumarng, S, Pitchakarn, P, Yodkeeree, S, Punfa, W, Mapoung, S, Ramli, RA, et al.. Modulation of P-glycoprotein by Stemona alkaloids in human multidrug resistance leukemic cells and structural relationships. Phytomedicine 2017;34:182\u201390. https:\/\/doi.org\/10.1016\/j.phymed.2017.08.004.","DOI":"10.1016\/j.phymed.2017.08.004"},{"key":"2026070716010034873_j_biol-2025-1340_ref_007","doi-asserted-by":"crossref","unstructured":"Uppar, PM, Harish, KK, Beeraka, NM, Xi, Z, Somu, C, Madegowda, M, et al.. Optimizing adamantane derivatives for enhanced EGFR inhibition in MCF-7 breast cancer cells. J\u00a0Mol Struct 2025:1331.","DOI":"10.1016\/j.molstruc.2025.141554"},{"key":"2026070716010034873_j_biol-2025-1340_ref_008","doi-asserted-by":"crossref","unstructured":"Moshtaghi, ZA, Abkar Aras, M, Jafari, N, Rezaei, Z, Hamishehkar, H. Green synthesis of new adamantane-containing dihydropyrimidine derivatives as potential anticancer agents. RSC Adv 2025;15:7949\u201355. https:\/\/doi.org\/10.1039\/d5ra00284b.","DOI":"10.1039\/D5RA00284B"},{"key":"2026070716010034873_j_biol-2025-1340_ref_009","doi-asserted-by":"crossref","unstructured":"Alamri, MA. Fluorophenyl adamantane derivatives anticancer activity and biological targets. J\u00a0Mol Struct 2025;1326:141103. https:\/\/doi.org\/10.1016\/j.molstruc.2024.141103.","DOI":"10.1016\/j.molstruc.2024.141103"},{"key":"2026070716010034873_j_biol-2025-1340_ref_010","doi-asserted-by":"crossref","unstructured":"Bukowski, K, Kciuk, M, Kontek, R. Mechanisms of multidrug resistance in cancer chemotherapy. Int J Mol Sci 2020;21:3233. https:\/\/doi.org\/10.3390\/ijms21093233.","DOI":"10.3390\/ijms21093233"},{"key":"2026070716010034873_j_biol-2025-1340_ref_011","doi-asserted-by":"crossref","unstructured":"Niu, J, Peng, D, Liu, L. Drug resistance mechanisms of acute myeloid leukemia stem cells. Front Oncol 2022;12:896426. https:\/\/doi.org\/10.3389\/fonc.2022.896426.","DOI":"10.3389\/fonc.2022.896426"},{"key":"2026070716010034873_j_biol-2025-1340_ref_012","doi-asserted-by":"crossref","unstructured":"Kropp, EM, Li, Q. Mechanisms of resistance to targeted therapies for relapsed or refractory acute myeloid leukemia. Exp Hematol 2022;111:13\u201324. https:\/\/doi.org\/10.1016\/j.exphem.2022.04.001.","DOI":"10.1016\/j.exphem.2022.04.001"},{"key":"2026070716010034873_j_biol-2025-1340_ref_013","doi-asserted-by":"crossref","unstructured":"Imrichova, D, Coculova, M, Messingerova, L, Sulova, Z, Breier, A. Vincristine-induced expression of P-glycoprotein in MOLM-13 and SKM-1 acute myeloid leukemia cell lines is associated with coexpression of nestin transcript. Gen Physiol Biophys 2014;33:425\u201331. https:\/\/doi.org\/10.4149\/gpb_2014015.","DOI":"10.4149\/gpb_2014015"},{"key":"2026070716010034873_j_biol-2025-1340_ref_014","doi-asserted-by":"crossref","unstructured":"Sofrankova, L, Spaldova, J, Stefik, P, Pavilek, B, Bortnak, D, Pavlikova, L, et al.. P-glycoprotein-independent cytotoxic effects of 5-aminopyrazole in L1210 leukemia cells. Eur J Med Chem Rep 2025;13:100246. https:\/\/doi.org\/10.1016\/j.ejmcr.2025.100246.","DOI":"10.1016\/j.ejmcr.2025.100246"},{"key":"2026070716010034873_j_biol-2025-1340_ref_015","doi-asserted-by":"crossref","unstructured":"Rai, Y, Pathak, R, Kumari, N, Sah, DK, Pandey, S, Kalra, N, et al.. Mitochondrial biogenesis and metabolic hyperactivation limits the application of MTT assay in the estimation of radiation induced growth inhibition. Sci Rep 2018;8:1531. https:\/\/doi.org\/10.1038\/s41598-018-19930-w.","DOI":"10.1038\/s41598-018-19930-w"},{"key":"2026070716010034873_j_biol-2025-1340_ref_016","doi-asserted-by":"crossref","unstructured":"Lyons, A, Coleman, M, Riis, S, Favre, C, O\u2019Flanagan, CH, Zhdanov, AV, et al.. Insulin-like growth factor 1 signaling is essential for mitochondrial biogenesis and mitophagy in cancer cells. J\u00a0Biol Chem 2017;292:16983\u201398. https:\/\/doi.org\/10.1074\/jbc.m117.792838.","DOI":"10.1074\/jbc.M117.792838"},{"key":"2026070716010034873_j_biol-2025-1340_ref_017","doi-asserted-by":"crossref","unstructured":"Scotti, C, Barlow, JW. Natural products containing the nitrile functional group and their biological activities. Nat Prod Commun 2022;17:1934578X221099973. https:\/\/doi.org\/10.1177\/1934578x221099973.","DOI":"10.1177\/1934578X221099973"},{"key":"2026070716010034873_j_biol-2025-1340_ref_018","doi-asserted-by":"crossref","unstructured":"Jornada, DH, Dos Santos Fernandes, GF, Chiba, DE, De Melo, TRF, Dos Santos, JL, Chung, MC. The prodrug approach: a successful tool for improving drug solubility. Molecules 2015;21:42. https:\/\/doi.org\/10.3390\/molecules21010042.","DOI":"10.3390\/molecules21010042"},{"key":"2026070716010034873_j_biol-2025-1340_ref_019","doi-asserted-by":"crossref","unstructured":"Hartyanszky, I, Kalasz, H, Adeghate, E, Gulyas, Z, Hasan, MY, Tekes, K, et al.. Active metabolites resulting from decarboxylation, reduction and ester hydrolysis of parent drugs. Curr Drug Metabol 2012;13:835\u201362. https:\/\/doi.org\/10.2174\/138920012800840437.","DOI":"10.2174\/138920012800840437"},{"key":"2026070716010034873_j_biol-2025-1340_ref_020","unstructured":"Van Ackern, K, Deuster, JE, Mast, GJ, Schmier, J. Effects of amantadine on heart and circulation. Arzneimittelforschung 1975;25:891\u20136."},{"key":"2026070716010034873_j_biol-2025-1340_ref_021","doi-asserted-by":"crossref","unstructured":"Lu, J, B\u00f6ttcher, M, Walther, T, Mougiakakos, D, Zenz, T, Huber, W. Energy metabolism is co-determined by genetic variants in chronic lymphocytic leukemia and influences drug sensitivity. Haematologica 2019;104:1830\u201340. https:\/\/doi.org\/10.3324\/haematol.2018.203067.","DOI":"10.3324\/haematol.2018.203067"},{"key":"2026070716010034873_j_biol-2025-1340_ref_022","doi-asserted-by":"crossref","unstructured":"Klawitter, J, Kominsky, DJ, Brown, JL, Klawitter, J, Christians, U, Leibfritz, D, et al.. Metabolic characteristics of imatinib resistance in chronic myeloid leukaemia cells. Br J Pharmacol 2009;158:588\u2013600. https:\/\/doi.org\/10.1111\/j.1476-5381.2009.00345.x.","DOI":"10.1111\/j.1476-5381.2009.00345.x"},{"key":"2026070716010034873_j_biol-2025-1340_ref_023","doi-asserted-by":"crossref","unstructured":"Vidal, RS, Quarti, J, Rumjanek, FD, Rumjanek, VM. Metabolic reprogramming during multidrug resistance in leukemias. Front Oncol 2018;8:90. https:\/\/doi.org\/10.3389\/fonc.2018.00090.","DOI":"10.3389\/fonc.2018.00090"},{"key":"2026070716010034873_j_biol-2025-1340_ref_024","doi-asserted-by":"crossref","unstructured":"Mynott, RL, Wallington-Beddoe, CT. Inhibition of P-Glycoprotein does not increase the efficacy of proteasome inhibitors in multiple myeloma cells. ACS Pharmacol Transl Sci 2021;4:713\u201329. https:\/\/doi.org\/10.1021\/acsptsci.0c00200.","DOI":"10.1021\/acsptsci.0c00200"},{"key":"2026070716010034873_j_biol-2025-1340_ref_025","doi-asserted-by":"crossref","unstructured":"Szab\u00f3, E, Kulin, A, Jezs\u00f3, B, Kucsma, N, Sarkadi, B, V\u00e1rady, G. Selective fluorescent probes for high-throughput functional diagnostics of the human multidrug transporter P-glycoprotein (ABCB1). Int J Mol Sci 2022;23:10599. https:\/\/doi.org\/10.3390\/ijms231810599.","DOI":"10.3390\/ijms231810599"},{"key":"2026070716010034873_j_biol-2025-1340_ref_026","doi-asserted-by":"crossref","unstructured":"Smyth, MJ, Krasovskis, E, Sutton, VR, Johnstone, RW. The drug efflux protein, P-glycoprotein, additionally protects drug-resistant tumor cells from multiple forms of caspase-dependent apoptosis. Proc Natl Acad Sci USA 1998;95:7024\u20139. https:\/\/doi.org\/10.1073\/pnas.95.12.7024.","DOI":"10.1073\/pnas.95.12.7024"},{"key":"2026070716010034873_j_biol-2025-1340_ref_027","doi-asserted-by":"crossref","unstructured":"Ruefli, AA, Tainton, KM, Darcy, PK, Smyth, MJ, Johnstone, RW. P-glycoprotein inhibits caspase-8 activation but not formation of the death inducing signal complex (disc) following Fas ligation. Cell Death Differ 2002;9:1266\u201372. https:\/\/doi.org\/10.1038\/sj.cdd.4401081.","DOI":"10.1038\/sj.cdd.4401081"}],"container-title":["Open Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/biol-2025-1340\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/biol-2025-1340\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T16:02:39Z","timestamp":1783440159000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/biol-2025-1340\/html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,1]]},"references-count":27,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,6,26]]},"published-print":{"date-parts":[[2026,1,23]]}},"alternative-id":["10.1515\/biol-2025-1340"],"URL":"https:\/\/doi.org\/10.1515\/biol-2025-1340","relation":{},"ISSN":["2391-5412"],"issn-type":[{"value":"2391-5412","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,1]]},"article-number":"20251340"}}